AACR24
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
AACR24
Apr 13, 2024, 07:26 |
Blog
Massimo Cristofanilli: Development of endocrine resistance can be associated with loss of ER expression in CTCs
Massimo Cristofanilli, Professor of Medicine and Director of Breast Medical Oncology, Division of Hematology/Oncology at Weill…
Apr 12, 2024, 17:36 |
Insight
Mark Yarchoan: Multicenter P1/2 trial of a personalized neoantigen vaccine + anti-PD1 in 2L HCC presented at AACR24
Mark Yarchoan, Associate Professor at Johns Hopkins Hospital, shared on X: "Multicenter P1/2 trial of…
Apr 12, 2024, 17:32 |
Blog
AACR thanks the thousands of participants in the AACR Annual Meeting in San Diego
AACR shared on their X/Twitter: ''We thank the thousands of participants in the AACR Annual…
Apr 12, 2024, 16:21 |
Societies
Vivek Subbiah: Where does the AACR24 Plenary Chair work with the ASCO Plenary Chair?
Vivek Subbiah shared a post on LinkedIn: "Where does the American Association for Cancer Research AACR24 Plenary…
Apr 12, 2024, 14:08 |
Insight
Erman Akkus: Pancreatic cancer clinical trials in AACR24
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X: "Pancreatic cancer clinical trials…
Apr 12, 2024, 13:44 |
Blog
Randy Larsen: Honored to receive a Scholar-in-training award from the Margaret Foti Foundation
Randy Larsen, Molecular Oncologist at St. Jude Graduate School of Biomedical Sciences, shared a post…
Apr 12, 2024, 13:02 |
Blog
Patrick Hwu: Congrats to AACR for a tremendous AACR24 Annual Meeting!
Patrick Hwu, President and CEO of Moffitt Cancer Center, shared a post on X/Twitter: "Congrats…
Apr 12, 2024, 12:47 |
Insight
Christine Lovly: Reflecting on AACR24
Christine Lovly shared on X/Twitter: "Reflecting on AACR24: - Phenomenal cancer science and medicine, -…
Apr 12, 2024, 11:49 |
Drugs
Vasileios Askoxylakis: Promising clinical data from the Phase 1 study of the CCR7 targeting antibody-drug conjugate JBH492
Vasileios Askoxylakis, Vice President, Global Head Oncology Early Clinical Development at Servier, shared on LinkedIn: "Very…
Apr 12, 2024, 11:02 |
Blog
Nicholas Navin: Systems Biology at the MD Anderson Cancer Center in Houston, Texas is recruiting faculty
Nicholas Navin, Professor and Chair, Department of Systems Biology at MD Anderson Cancer Center, shared on…
2
3
4
5
6
All:
128
Posts:
31 - 40
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube